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accelerated cardiovascular failure in diabetic patients. Even though the exact mechanism(s) behind this disease still remain unclear, research from several laboratories including our own suggests that reactive oxygen species (ROS) play a very important role in the development of DCM.
In our lab, we have developed and characterized a diabetic transgenic mice line, designated OVE26, which clearly develops diabetic cardiomyopathy. Comparison of protein expression patterns in the hearts of 120-day-old control and diabetic mice reveals 22 proteins that are differentially expressed in OVE26 mice hearts, most of which are involved in energy metabolism. Surprisingly, 10 of 20 proteins that are identified by mass spectrometry are located in mitochondria, suggesting mitochondria as a critical target for ROS damage. The finding of the up-regulation of all 10 proteins also corresponds well with the concept that moderate oxidative stress can stimulate mitochondrial biosynthesis to compensate for the impaired cell functions. Study on mitochondrial morphology also shows abnormal cardiac structure and damage, further pointing to mitochondria as one of the major sites of ROS attack in diabetic cardiomyopathy.
v In an effort to prevent the mitochondrial damage we saw in diabetic hearts, we have developed transgenic lines that overexpress the main mitochondrial antioxidant protein, MnSOD specifically in cardiomyocytes. Preliminary data from the transgenic mice that overexpress MnSOD in diabetic heart showed that this antioxidant enzyme was effective in protecting the morphology of the diabetic heart.
Our proteomic and morphologic analyses indicate that mitochondria are an important target of diabetic cardiomyopathy.
Protection by overexpression of mitochondrial MnSOD indicates that ROS are involved in this damage. available now and the pathogenesis of this disease is still unclear. In addition, little emphasis has been put on developing novel approaches to prevention and treatment of diabetic cardiomyopathy. We are expecting to make progress in characterizing the role of mitochondrial ROS and mitochondrial damage in this disease through this study, and also to shed some light on the potential application of antioxidant therapy.
In order to study diabetic cardiomyopathy, our laboratory has developed and characterized a diabetic transgenic mice line, designated OVE26 (15-18). These transgenic mice develop very early onset of diabetes due to the overexpression of the calcium binding protein calmodulin in pancreatic beta cells that induces pancreatic beta cell death and dysfunction. The exact mechanism of why elevated calmodulin was remarkably deleterious to β cells is still poorly understood, but it has been suggested that abnormal calcium homeostasis is harmful for both function and viability of β cells (16).
The OVE26 transgenic mice provide us an excellent model to study diabetic complications. Transgenic mice demonstrate elevated blood glucose levels within the first days of life and have blood glucose values over 450 mg/dl by 30 to 55 days of age.
By the time when they are 120 days old, the typical blood glucose values are over 600 mg/dl. Surprisingly, they can survive at least a year without exogenous insulin therapy despite such high blood glucose levels. The specificity of the transgene and insulin promoter assures that calmodulin only induces the degeneration of pancreatic β cells.
Since the diabetes is induced genetically, they require no administration of any beta cell toxin that might induce variability and nonspecific toxicity. Successive generations have continued to express their characteristic of very early onset of diabetes for more than 10 years now. They are readily maintained because they are fertile up to 4 months of age. To better understand this disease on the molecular level, we decided to study changes in protein expression in an effort to reveal the mechanism of these deficits and some targets of ROS damage.
Proteomic analysis is chosen for this purpose because of the many advantages it offers over other methods for analysis of protein expression. Unlike Western blots which can examine the expression of only one protein at a time and which is limited by the availability of antibodies, proteomic analysis can examine the abundance of hundreds to thousands of proteins on one gel (21). What's more, proteomic analysis is able to detect some post-translational modifications. For example, it is possible to observe the different phosphorylation states of one protein by the presence of a series of protein spots with similar MW since the addition or the subtraction of phosphate groups will make detectable change on pI but not on molecular weight (22).
In the following study, we applied proteomic analysis to 4-month old FVB and OVE26 hearts to study the change of protein expressions in diabetic cardiomyopathy.
Proteomic results combined with the observation from cardiac morphology strongly suggest that mitochondria are going through certain changes in this disease.
CHAPTER II

MATERIALS AND METHODS
Animals: We have previously described the development of OVE26 diabetic mice (Epstein, Overbeek, and Means 1989) . Transgenic mice were recognized by the presence of small eyes caused by co-integration of the GR19 gene (Epstein, Overbeek, and Means 1989) . All transgenic and non-transgenic mice were maintained on the inbred FVB background.
Whole heart protein extraction: Fresh heart taken from 4-month-old control and diabetic mice were immediately rinsed in pre-chilled PBS to wash out the blood. The heart was then frozen in liquid nitrogen and later transferred to -80˚C freezer for storage.
On the day before running the 2-D gel, the heart was powdered, weighed, and homogenized on ice in 600ml sample buffer/100mg heart tissue. The sample buffer contained 7 M urea, 1.9 M thiourea, 4% CHAPS, 58 mM DTT and 4.45% pH 3-10 carrier ampholytes. The mixture was shaken in cold room for one hour and centrifuged at 16,000g for 10 minutes at 4 degree. The supernatant containing the soluble proteins was removed and aliquoted to microtubes for further use. Protein concentration was determined using Bio-Rad protein assay based on Bradford's method (Bradford 1976 This image was then used to determine the existence and differential expression of proteins in each group. Background of the gel was subtracted using "Average on the boundary" and the spot intensity was normalized by using "total volume ratio x total spot area" to minimize the intensity variability among the gels. A t-test was used to compare the protein intensities in control and diabetic hearts, and p≤0.05 was considered significant.
Protein spot picking and in-gel tryptic digestion: The protein spots were excised with a clean scalpel into 1 mm cube and transferred to clean 1.5 ml microtubes. The gel pieces were washed and sequentially dehydrated and rehydrated by the methods used described by Thongboonkerd, et al. (Thongboonkerd et al 2002) . Then the gel tubes were chopped into smaller pieces and incubated with 20 ng/ul modified trypsin (Promega, Madison, WI) in 50 mM ammonium bicarbonate at 37˚C overnight in shaking incubator.
MALDI-TOF mass spectrometry: The samples were desalted and spotted onto the 96-well MALDI target plate by the method described by Thongboonkerd, et al. (Thongboonkerd, Luengpailin, Cao, Pierce, Cai, Klein, and Doyle 2002) . Mass spectral data were obtained using a Micromass Tof-Spec 2E instrument with a 337 mM N 2 laser. Heart morphology: Cardiac ultrastructure was examined by transmission electron microscopy (TEM) in hearts of control and transgenic mice at the age of 4-5 month.
Hearts from anesthetized animals were first perfused with an approximately 30 ml of wash-out solution containing procaine hydrochloride to prevent vasoconstriction and a relatively weak solution of paraformaldehyde to pre-fix the heart, followed by the full- adding 25ul of 2 mM pyrogallol in 10 mM HCl, and the increase in absorbance at 405 nm was followed for 2 minutes by SPECTRA Fluor Plus plate reader (Tecan U.S. Inc., Durham, NC). SOD activity was assessed as the degree of inhibition of the pyrogallol autoxidantion rate. An inhibition of 50% by SOD standard was defined as 1 unit SOD.
Sample protein concentration was measured by BCA method (Smith et al 1985) . The final results were reported as SOD Units/mg of protein.
CHAPTER III
RESULTS
Mice cardiac protein expression: The pattern of protein expression in mice heart by two-dimensional PAGE was consistent and identical for over 80% of all protein spots in 10 control and diabetic heart samples. Hundreds of proteins were visualized on the gel and over two hundred spots were detected by gel image analysis software. Figure 1 is a typical two-dimensional gel image showing the cardiac protein expression pattern in mice.
Altered protein expression in diabetic heart: In our proteomic analysis comparing five control hearts to five OVE26 hearts, twenty-two proteins are found significantly altered in abundance, most of which have increased abundance in diabetic hearts. The positions of these proteins are shown in Figure 1 by red arrowheads. Twenty of them gave signal strong enough to be identified by the mass spectrometry (Table 1) .
Among these twenty differentially expressed proteins, more than half of them are involved in energy metabolism, such as aconitase and isocitrate dehydrogenase for TCA cycle, enolase and aldolase for glycolysis, as well as 3-ketoacyl-CoA thiolase for fatty acid beta-oxidation. Some proteins are known to be induced by stress, such as prohibitin and crystallin. There are also some proteins with unknown functions such as HSPC326.
Very surprisingly, 10 of these 20 proteins are in the mitochondria, and all of them are up-regulated in diabetes. It has been reported that within a certain threshold, elevated ROS or reduced ATP production can induce a type of stress response to compensate impaired mitochondrial function by stimulating mitochondrial biosynthesis and/or increasing the expression of the genes required for energy metabolism (Fosslien 2001; Heddi et al 1999; Lee and Wei 2000) . The fact that so many mitochondrial proteins are altered in abundance in diabetic heart also suggests that mitochondria might be a crucial target for ROS attack in diabetic cardiomyopathy.
Mitochondrial morphology in OVE26 heart: In order to further investigate the possible mitochondrial damage in diabetic cardiomyopathy, transmission electron micrographs (TEM) of left ventricular myocardium were taken in FVB and OVE26 mice to look into the mitochondrial morphology at different ages. Figure 2 shows the cardiac ultrastructure at 2, 5 and 11 months of age in control (A,C,E) and diabetic (B,D,F) heart.
The data clearly indicate the development of cardiomyopathy in our transgenic mice and the progressive damage to mitochondria over the time course. By the age of two months, OVE26 hearts began to show disarrangement of myofilaments and disruption of sarcomeres (Figure 2, panel A and B) while the mitochondria still kept normal structure and appearance. At 5 months, mitochondria abnormalities such as broken membranes and cristae as well as rarified matrices became evident (panel C and D). By eleven months of age, damages to both myofibrils and mitochondria were exacerbated, myelin figures become prominent and the overall cytoarchitecture was disrupted (panel E and F).
A closer look at the cardiac mitochondria at 300-day-old diabetic mice (Figure 3) confirmed the damage we see in Figure 2 . In some area, mitochondria are swollen or in irregular shape, some of them are even broken. Instead of the homogeneous dense matrix we see in the same age control heart, OVE26 mitochondria matrix was rarified and irregularly distributed.
The mitochondrial damage we observed in diabetic heart EM photographs combined with the proteomics results strongly suggest that mitochondrial structure and probably function are impaired in diabetic cardiomyopathy, and this further leads to the compensatory induction of the proteins involved in energy metabolism.
MnSOD protection: In an effort to prevent the abnormalities we saw in diabetic cardiomyopathy, especially the damage to mitochondria, we have developed transgenic lines that overexpress the major mitochondrial antioxidant enzyme, manganese superoxide dismutase (MnSOD), specifically in heart. The transgene shown in Figure 4 is constructed as described in methods.
Characterization of these MnSOD transgenic lines is still in progress. Initial study done in 3 of the 5 transgenic lines shows the SOD activities in the heart were 30-60 fold higher compared to FVB mice ( Figure 5 ). The increased SOD protein expression was also confirmed by two-dimension PAGE ( Figure 6 ).
We have just obtained data from the first OVE26-MnSOD mice. While this data is very preliminary and from only one OVE26-MnSOD mouse it clearly suggests that MnSOD protected the heart from diabetes-induced damage to overall structure, cardiomyofibils, as well as mitochondria. As shown in Figure 7 , OVE26-MnSOD diabetic hearts were protected from the damage seen in diabetic OVE26 hearts. Activities are shown as the fold increase in transgenic mice vs. control mice. Data were obtained from the mean of 2-5 mice in each of four groups. Assay will be repeated later with more animals to confirm these results. 
CHAPTER IV
DISCUSSION
Cardiovascular disease is the major cause of morbidity and mortality from diabetes mellitus. In this paper, we studied the changes of protein expression in diabetic cardiomyopathy through our diabetic animal model -OVE26 transgenic mice. It is the first time for researchers to study systematically the protein expression in this disease.
Proteomic analysis revealed over 20 proteins with altered abundance in a 4-month-old diabetic heart, most of which are involved in energy metabolism. We also noticed an unexpected high proportion of mitochondrial proteins that were altered. The fact that all of them are upregulated suggests that this compartment might be undergoing cellular damage in the diabetic state and a certain compensatory response is induced. Results from morphological study of cardiac mitochondria also showed progressive damage to its ultrastructure and appearance, further confirming our suspicions.
Accumulating evidence suggests that reactive oxygen species (ROS) play a very important role in the development of diabetic cardiomyopathy, and mitochondria are the main source of ROS in the cell under most conditions. Excess ROS had been shown to be widely involved in diabetes and its many complications (Baynes 1991) . Whether the superoxide produced by the mitochondria is upregulated in diabetes is still unclear.
However, aside from the well-known fact that mitochondria are the main intracellular source of oxidative stress, they are also the major target of ROS that are continually generated as the by-products from the respiratory chain under normal physiological conditions (Lee and Wei 2000) . It has been suggested that a decline in mitochondrial function plays a critical role in aging and other degenerative diseases by producing excess ROS due to defects in the electron transport chain (Lee and Wei 2000; Wallace 1999 ).
Mitochondrial damage and dysfunction has been widely reported in diabetes and cardiomyopathy. Several laboratories including our own have found severe mitochondrial structural damage in diabetic heart electronmicrographs (Giacomelli and Wiener 1979) .
Evidence for mitochondrial dysfunction include depressed state 3 respiration and ATPase activity, decreased mitochondrial calcium uptake, as well as defective oxidative phosphorylation (OXPHOS) (Pierce and Dhalla 1985) . Decreased pyruvate dehydrogenase activity and reduced activities of Complex I and Complex V have also been reported in the heart of STZ-induced diabetic animal models (Flarsheim et al 1996; Tomita et al 1996) . Moreover, mitochondrial DNA (mtDNA) mutations have also been implicated in diabetes (Flarsheim, Grupp, and Matlib 1996; Graff et al 1999) . Some characteristics of mitochondria such as a lack of protective histones for mtDNA and absence of an efficient repair system render mtDNA vulnerable to oxidative insult by ROS and prone to mutations (Lee and Wei 2000) . Mutations in mtDNA can in turn deteriorate OXPHOS and reduce mitochondrial energy production (Esposito et al 1999) .
Because heart exclusively relies on mitochondrial ATP synthesis for contraction and ion transport, it makes sense that defective energy production would preferentially affect the heart (Wallace 2000) . In diabetic heart, long-term exposure to ROS might result in defective oxidative phosphorylation and bioenergy production, leading further to the development of cardiomyopathy. Our finding of upregulation of a significant number of mitochondrial proteins in diabetic cardiomyopathy is well in accordance with the above theory.
Another possible explanation for the elevated percentage of mitochondrial proteins was that the mitochondrial mass was increased in 120-day-old diabetic mice. In morphological study, we did see swollen cardiac mitochondria with increased mass in the mice of 11 months age ( Figure 2F ). However, this increase was not so distinct in 5month-old diabetic heart ( Figure 2D ), and we consider it to be a minor factor that counted for the high proportion of mitochondrial proteins in 4-month-old diabetic hearts as we saw in proteomic results.
From the severe damage we saw in mitochondrial morphology, it is reasonable to postulate that mitochondrial function might be affected by ROS attack as well. Our next study is to investigate mitochondrial integrity and activity under the diabetic state. Initial data from Shirong Zheng, a postdoctoral fellow in our laboratory, shows that in OVE26 cardiac mitochondria, even though P/O remains the same as control, RCR is significantly decreased (data not shown), suggesting impaired control of mitochondrial metabolism and possibly reduced rate of ATP synthesis. We will also measure the activities of four complexes in mitochondrial electron transport chain to study the effect of oxidative stress on mitochondrial functions.
In support of our hypothesis that ROS induced mitochondrial damage in diabetic cardiomyopathy, initial results from MnSOD transgenic mice has shown that overexpression of MnSOD in diabetic heart successfully blocked diabetes-induced damage in heart morphology. Since MnSOD only protects against ROS, this result suggests that ROS causes the morphology damage in diabetic hearts. We are planning to further study the protective effect of MnSOD in diabetic heart from protein expression, ROS production, mitochondrial function, as well as cardiomyocyte contractility. These studies will be a part of our continued efforts to find an effective antioxidant regimen for the prevention or treatment of diabetic complications.
